HIMSS Media Insights on Technology Disruption in Healthcare

Janet King and Leonard D’Avolio, Assistant Professor at Brigham and Women’s and Harvard Medical School, will convene to discuss the results of a recent HIMSS Media survey, which polled healthcare providers on their outlook for the future of healthcare IT, with a focus on disruptive technologies. The survey explores the importance of each aspect of the quadruple aim, the role of technology in advancing key goals, the use/adoption of technologies like cloud computing, AI/Machine Learning, IoT and blockchain, and the implications of those technologies for the future of healthcare. Leonard, a healthcare tech visionary, will provide commentary on the results, and how he sees technology shaping the future of healthcare.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Application of Machine Learning in Healthcare

Bestintown Analytics

Cancer has been characterized as a heterogeneous disease consisting of many different subtypes. The early diagnosis and prognosis of a cancer type have become a necessity in cancer research, as it can facilitate the subsequent clinical management of patients. In this webinar, we'll discuss the Application MachineLearning especially Support Vector Machines in Cancer Detection.
Watch Now

Overview of Nursing Liability

Lorman

Being a licensed nursing professional sends the message to patients that you have been educated, trained and are competent in your practice. Unfortunately, in today's increasingly litigious society, claimants take the position that all bad outcomes are the result of professional negligence and target licensed professionals, their employers and insurance carriers as being in violation of the practice act, the standard of care and/or the criminal statutes. The allegations take the form of administrative complaints, lawsuits or prosecutions.
Watch Now

De-risk therapeutic antibody drug development using humanized fcrn mice

Jax

Do you need reliable pharmacokinetic data (PK) to evaluate human immunoglobulin or albumin-based therapeutic drug candidates? The humanized FcRn (Hu-FcRn) mouse model enables you to obtain clinically-relevant PK data related to drug half-life. This critically important PK data helps optimize the design of preclinical efficacy studies and to de-risk lead selection.
Watch Now

How Has COVID Permanently Changed Healthcare

COVID-19 transformed how we collectively delivered care in 2020. Not only are we seeing an upending of traditional health care settings, but patients increasingly expect to know the costs of their care ahead of time.
Watch Now